Sign up to save your podcasts
Or
Share TBT – The Top Papers of 2022
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
TBT – The Top Papers of 2022
Send us a text
Welcome back Rounds Table Listeners! As we approach the end of 2023, let’s revisit five important research studies from 2022: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial (0:00 – 2:56) Tirzepatide Once Weekly for the Treatment of Obesity (2:56 – 6:00) Empagliflozin in Patients with Chronic Kidney Disease (6:00 – ...
The post TBT – The Top Papers of 2022 appeared first on Healthy Debate.
View all episodes
By Dr. John Fralick and Dr. Michael Fralick
5
1212 ratings
Send us a text
Welcome back Rounds Table Listeners! As we approach the end of 2023, let’s revisit five important research studies from 2022: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial (0:00 – 2:56) Tirzepatide Once Weekly for the Treatment of Obesity (2:56 – 6:00) Empagliflozin in Patients with Chronic Kidney Disease (6:00 – ...
The post TBT – The Top Papers of 2022 appeared first on Healthy Debate.
More shows like The Rounds Table
View all
JAMA Editors' Summary
129 Listeners
Emergency Medicine Cases
538 Listeners
Core EM - Emergency Medicine Podcast
250 Listeners
JAMA Clinical Reviews
493 Listeners
GeriPal - A Geriatrics and Palliative Care Podcast
285 Listeners
The Curbsiders Internal Medicine Podcast
3,332 Listeners
Core IM | Internal Medicine Podcast
1,090 Listeners
Annals On Call Podcast
185 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Run the List
248 Listeners
Cardionerds: A Cardiology Podcast
426 Listeners
Critical Care Scenarios
249 Listeners
The Curious Clinicians
366 Listeners
Critical Care Time
219 Listeners